Treatments that show promise…
…don’t always pan out.
But this definitely shows promise for those COVID patients who are in dire straits:
Six critically ill coronavirus patients in Israel who are considered high-risk for mortality have been treated with Pluristem’s placenta-based cell-therapy product and survived, according to preliminary data provided by the Haifa-based company.
The patients were treated at three different Israeli medical centers for one week under the country’s compassionate use program and were suffering from acute respiratory failure and inflammatory complications associated with COVID-19. Four of the patients also demonstrated failure of other organ systems, including cardiovascular and kidney failure.
[Hat tip: commenter “sdferr.”]
Thanks, Neo!
People are developing a large menu of treatments and tests. These will enable us to restart the economy after a while, even though the Trump-haters are throwing up roadblocks.
Not yet enough details, are these stem cells from the placenta? What about from umbilical cord – where there are already companies collecting such blood.
Likely among many treatments coming; good news for the world.
Thanks, Israel!